Aseptika Ltd began developing Activ8rlives in 2010 and is currently developing its fourth generation of integrated systems, which can be used by consumers and their healthcare service providers using a wide range of platforms or devices to better enable effective and easy self-monitoring. Incorporating sensors and monitors ranging from consumer accessories to in vitro diagnostics (IVDs). Our focus is: respiratory and cardiovascular disease, cancer, promoting physical activity and weight management. Aseptika specialises in developing smart inhalers for patients with long-term respiratory conditions, which has been co-funded by the UK’s Innovation Agency, Innovate UK. Aseptika third-generation smart inhaler tracker, which will have IoT connectivity built-in. This means that patients, young or old, will no longer have to send their data via a smartphone to their clinical teams, carers or parents—it will just send information over the airwaves directly to the Cloud Servers. Aseptika Limited is certified by BSI to ISO 13485:2016 under certificate number MD691414.
View Top Employees from Activ8rlives (Aseptika Ltd)Website | http://www.activ8rlives.com |
Revenue | $6.7 million |
Employees | 9 (9 on RocketReach) |
Founded | 2007 |
Phone | +44 1480 352821 |
Industry | Medical Equipment Manufacturing, Manufacturing General, Health Care, Manufacturing, Medical Device |
Competitors | Kinetik Medical Devices Limited, OMRON HEALTHCARE UK LIMITED, PROACT Medical Ltd, Quadratech Diagnostics Ltd |
SIC | SIC Code 384 Companies, SIC Code 38 Companies |
NAICS | NAICS Code 339 Companies, NAICS Code 33 Companies |
Looking for a particular Activ8rlives (Aseptika Ltd) employee's phone or email?
The Activ8rlives (Aseptika Ltd) annual revenue was $6.7 million in 2024.
Kevin Auton is the Managing Director of Activ8rlives (Aseptika Ltd).
9 people are employed at Activ8rlives (Aseptika Ltd).
The NAICS codes for Activ8rlives (Aseptika Ltd) are [339, 33].
The SIC codes for Activ8rlives (Aseptika Ltd) are [384, 38].